Advertisement

Topics

FDA approves new treatment for a rare genetic disorder, Fabry disease

12:37 EDT 10 Aug 2018 | FDA

FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

Original Article: FDA approves new treatment for a rare genetic disorder, Fabry disease

NEXT ARTICLE

More From BioPortfolio on "FDA approves new treatment for a rare genetic disorder, Fabry disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...